SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T‐Cells Infiltration and Immunosuppression
Advanced Science · 2024-09 · 11 (36)
DOI: 10.1002/advs.202310304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 29.07.2024. Verfasst von Xiangyuan Luo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji H…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, T-Lymphocytes, Regulatory, SOXC Transcription Factors. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, the Basic Research Support Program of Huazhong University of Science and Technology.
Abstract (Originalsprache)
Despite the success of immunotherapy in treating hepatocellular carcinoma (HCC), HCC remains a severe threat to health. Here, a crucial transcription factor, SOX12, is revealed that induces the immunosuppression of liver tumor microenvironment. Overexpressing SOX12 in HCC syngeneic models increases intratumoral regulatory T‐cell (Treg) infiltration, decreases CD8 + T‐cell infiltration, and hastens HCC metastasis. Hepatocyte‐specific SOX12 knockout attenuates DEN/CCl 4 ‐induced HCC progression and metastasis, whereas hepatocyte‐specific SOX12 knock‐in accelerates these effects. Mechanistically, SOX12 transcriptionally activates C‐C motif chemokine ligand 22 ( CCL22 ) expression to promote the recruitment and suppressive activity of Tregs. Moreover, SOX12 transcriptionally upregulates CD274 expression to suppress CD8 + T‐cell infiltration. Either knockdown of CCL22 or PD‐L1 dampens SOX12‐mediated HCC metastasis. Blocking of CC chemokine receptor 4 (CCR4), a receptor for CCL22, by inhibitor C‐021 or Treg‐specific knockout of CCR4 inhibits SOX12‐mediated HCC metastasis. Transforming growth factor‐β1 (TGF‐β1)/TGFβR1‐Smad2/3/4 is identified as a key upstream signaling for SOX12 overexpression in HCC cells. Combining C‐021 or TGFβR1 inhibitor galunisertib with anti‐PD‐L1 exhibits an enhanced antitumor effect in two HCC models. Collectively, the findings demonstrate that SOX12 contributes to HCC immunosuppression through the CCL22/CCR4‐Treg and PD‐L1‐CD8 + T axes. Blocking of CCR4 or TGFβR1 improves the efficacy of anti‐PD‐L1 in SOX12‐mediated HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and…
- Hepatic Surgery Center, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Clinical Medicine Research Center for Hepatic…
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University…
- The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics and Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering,…
- Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicin…
ORCID-Profile: Xiangyuan Luo, Limin Xia
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- the Basic Research Support Program of Huazhong University of Science and Technology
Zitieren
APA
Luo, X., Huang, W., Li, S., Sun, M., Hu, D., Jiang, J., Zhang, Z., Wang, Y., Wang, Y., Zhang, J., Wu, Z., Ji, X., Liu, D., Chen, X., Zhang, B., Liang, H., Li, Y., Liu, B., Wang, S., …, & Xia, L. (2024). SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T‐Cells Infiltration and Immunosuppression. Advanced Science, 11(36). https://doi.org/10.1002/advs.202310304
Vancouver
Luo X, Huang W, Li S, Sun M, Hu D, Jiang J, et al. SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T‐Cells Infiltration and Immunosuppression. Advanced Science. 2024;11(36). doi:10.1002/advs.202310304
BibTeX
@article{Luo2024,
author = {Luo, Xiangyuan and Huang, Wenjie and Li, Siwen and Sun, Mengyu and Hu, Dian and Jiang, Junqing and Zhang, Zerui and Wang, Yijun and Wang, Yufei and Zhang, Jiaqian and Wu, Zhangfan and Ji, Xiaoyu and Liu, Danfei and Chen, Xiaoping and Zhang, Bixiang and Liang, Huifang and Li, Yiwei and Liu, Bifeng and Wang, Shuai and Xu, Xiao and Nie, Yongzhan and Wu, Kaichun and Fan, Daiming and Xia, Limin},
title = {SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T‐Cells Infiltration and Immunosuppression},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {36},
doi = {10.1002/advs.202310304}
}
EUVIMED